Mechanism(s) involved in carbon monoxide-releasing molecule-2-mediated cardioprotection during ischaemia-reperfusion injury in isolated rat heart

Indian Journal of Pharmaceutical Sciences

Volumn 74, Issue 4, 2012, Pages 281-291

  Soni, H M ^a,b   Jain, M R ^a   Mehta, Anita A ^c  

^a ZYDUS RESEARCH CENTRE   (India)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c L M COLLEGE OF PHARMACY   (India)

Author keywords

Carbon monoxide releasing molecule 2; cardioprotection; ischaemia reperfusion; Langendorff s heart

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; CARBONYL DERIVATIVE; CREATINE KINASE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; TALMAPIMOD; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; ENZYME ACTIVATION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART PROTECTION; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TREATMENT DURATION;

EID: 84875536674     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.107047     Document Type: Article

References (45)

1. Chance B, Erecinska M, Wagner M. Mitochondrial responses to carbon monoxide toxicity. Ann N Y Acad Sci 1970;174:193-204
2. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: Unleashing the protective properties of heme. Trends Immunol 2003;24:449-55
3. Perrella MA, Yet SF. Role of heme oxygenase-1 in cardiovascular function. Curr Pharm Des 2003;9:2479-87
4. Vulapalli SR, Chen Z, Chua BH, Wang T, Liang CS. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol 2002;283:H688-94
5. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001;89:168-73
6. Fujimoto H, Ohno M, Ayabe S, Kobayashi H, Ishizaka N, Kimura H, et al. Carbon monoxide protects against cardiac ischemia-reperfusion injury in vivo via MAPK and Akt-eNOS pathways. Arterioscler Thromb Vasc Biol 2004;24:1848-53
7. Motterlini R, Mann BE, Johnson TR, Clark JE, Foresti R, Green CJ. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 2003;9:2525-39
8. Józkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R,et al. Heme oxygenase and angiogenic activity of endothelial cells: Stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 2003;5:155-62
9. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR,Mann BE, et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003;93:e2-8
10. Kim HP, Wang X, Nakao A, Kim SI, Murase N, Choi ME, et al. Caveolin-1 expression by means of p38beta mitogen-Activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc Natl Acad Sci USA 2005;102:11319-24
11. Otterbein LE, Choi AM. Heme oxygenase: Colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000;279:L1029-37
12. Ryter SW, Choi AM. Heme oxygenase-1/carbon monoxide: From metabolism to molecular therapy. Am J Respir Cell Mol Biol 2009;41:251-60
13. Shin DY, Chung J, Joe Y, Pae HO, Chang KC, Cho GJ, et al. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways. Blood 2012;119:2523-32
14. Winburn IC, Gunatunga K, McKernan RD, Walker RJ, Sammut IA,Harrison JC. Cell damage following carbon monoxide releasing molecule exposure: Implications for therapeutic applications. Basic Clin Pharmacol Toxicol 2012;111:31-41
15. Kramkowski K, Leszczynska A, Mogielnicki A, Chlopicki S,Fedorowicz A, Grochal E, et al. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules. Arterioscler Thromb Vasc Biol 2012;32:2149-57
16. Soni H, Patel P, Rath AC, Jain M, Mehta AA. Cardioprotective effect with carbon monoxide releasing molecule-2 (CORM-2) in isolated perfused rat heart: Role of coronary endothelium and underlying mechanism. Vascul Pharmacol 2010;53:68-76
17. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000;278:H643-51
18. Hangaishi M, Ishizaka N, Aizawa T, Kurihara Y, Taguchi J, Nagai R,et al. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 2000;279:582-8
19. Masini E, Vannacci A, Marzocca C, Pierpaoli S, Giannini L,Fantappié O, et al. Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart. Exp Biol Med (Maywood) 2003;228:546-9
20. Yoshida T, Maulik N, Ho YS, Alam J, Das DK. H (mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 2001;103:1695-701
21. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004;286:H1649-53
22. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, et al. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 2005;38:127-34
23. Lavitrano M, Smolenski RT, Musumeci A, Maccherini M, Slominska E,Di Florio E, et al. Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J 2004;18:1093-5
24. Akamatsu Y, Haga M, Tyagi S, Yamashita K, Graça-Souza AV, Ollinger R,et al. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 2004;18:771-2
25. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE,Green CJ. Carbon monoxide-releasing molecules: Characterization of biochemical and vascular activities. Circ Res 2002;90:E17-24
26. Lechner C, Zahalka MA, Giot JF, Møller NP, Ullrich A. ERK6,a mitogen-Activated protein kinase involved in C2C12 myoblast differentiation. Proc Natl Acad Sci USA 1996;93:4355-9
27. Li Z, Jiang Y, Ulevitch RJ, Han J. The primary structure of p38 gamma: A new member of p38 group of MAP kinases. Biochem Biophys Res Commun 1996;228:334-40
28. Jiang Y, Gram H, Zhao M, New L, Gu J, Feng L, et al. Characterization of the structure and function of the fourth member qof p38 group mitogen-Activated protein kinases, p38delta. J Biol Chem 1997;272:30122-8
29. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 1997;235:533-8
30. Nebreda AR, Porras A. p38 MAP kinases: Beyond the stress response. Trends Biochem Sci 2000;25:257-60
31. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005;15:11-8
32. Ryter SW, Morse D, Choi AM. Carbon monoxide: To boldly go where NO has gone before. Sci STKE 2004;2004:RE6
33. Kummer JL, Rao PK, Heidenreich KA. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-Activated protein kinase. J Biol Chem 1997;272:20490-4
34. Song R, Zhou Z, Kim PK, Shapiro RA, Liu F, Ferran C, et al. Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. J Biol Chem 2004;279:44327-34
35. Pae HO, Oh GS, Choi BM, Chae SC, Kim YM, Chung KR, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004;172:4744-51
36. Zhang X, Shan P, Alam J, Fu XY, Lee PJ. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J Biol Chem 2005;280:8714-21
37. Kohmoto J, Nakao A, Stolz DB, Kaizu T, Tsung A, Ikeda A,et al. Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. Am J Transplant 2007;7:2279-90
38. Ooie T, Takahashi N, Nawata T, Arikawa M, Yamanaka K,Kajimoto M, et al. Ischemia-induced translocation of protein kinase C-mediates cardioprotection in the streptozotocin-induced diabetic rat. Circ J 2003;67:955-61
39. Inagaki K, Hahn HS, Dorn GW II, Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with ?-protein kinase C inhibitor and ?-protein kinase C activator. Circulation 2003;108:869-75
40. Immenschuh S, Kietzmann T, Hinke V, Wiederhold M, Katz N,Muller-Eberhard U. The rat heme oxygenase-1 gene is transcriptionally induced via the protein kinase A signaling pathway in rat hepatocyte cultures. Mol Pharmacol 1998;53:483-91
41. Krönke G, Bochkov VN, Huber J, Gruber F, Blüml S, Fürnkranz A,et al. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem 2003;278:51006-14
42. Alvarez-Maqueda M, El Bekay R, Alba G, Monteseirín J, Chacón P,Vega A, et al. 15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. J Biol Chem 2004;279:21929-37
43. Salinas M, Diaz R, Abraham NG, Ruiz de Galarreta CM, Cuadrado A. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J Biol Chem 2003;278:13898-904
44. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3 beta during preconditioning through a phosphatidylinositol-3- kinase-dependent pathway is cardioprotective. Circ Res 2002;90:377-9
45. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 2005;288:H971-6